Monoclonal Antibody to Visfatin (VF)
Nampt; NAmPRTase; PBEF; PBEF1; Pre-B-Cell Colony Enhancing Factor; Nicotinamide Phosphoribosyltransferase
- Product No.MAA638Ra21
- Organism SpeciesRattus norvegicus (Rat) Same name, Different species.
- SourceMonoclonal antibody preparation
- Potency (Clone Number)D4
- Ig Isotype IgG1 Kappa
- PurificationProtein A + Protein G affinity chromatography
- Immunogen RPA638Ra01-Recombinant Visfatin (VF)
- Buffer Formulation0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
- Organism Species MoreHomo sapiens (Human), Mus musculus (Mouse)
- ApplicationsWB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
- DownloadInstruction Manual
200µl 1ml 10ml
For more details, please contact local distributors! US$ 253 FREE TRIAL
For more details, please contact local distributors! US$ 362 FREE TRIAL
For more details, please contact local distributors! US$ 905 FREE TRIAL
For more details, please contact local distributors! US$ 3620 FREE TRIAL
For more details, please contact local distributors!
The antibody is a mouse monoclonal antibody raised against VF. It has been selected for its ability to recognize VF in immunohistochemical staining and western blotting.
Western blotting: 0.5-2µg/mL;1:500-2000
Optimal working dilutions must be determined by end user.
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Antibody Labeling Customized Service
- Protein A/G Purification Column
- Staining Solution for Cells and Tissue
- Loading Control Antibodies
- Positive Control for Antibody
- Tissue/Sections Customized Service
- Phosphorylated Antibody Customized Service
- Immunohistochemistry (IHC) Experiment Service
- Immunocytochemistry (ICC) Experiment Service
- Flow Cytometry (FCM) Experiment Service
- Immunoprecipitation (IP) Experiment Service
- Immunofluorescence (IF) Experiment Service
- DAB Kit
- SABC Kit
- Long-arm Biotin Labeling Kit
|Brazilian Journal of Biomoricity||EFFECT OF 8 WEEKS ENDURANCE TRAINING ON PLASMA VISFATIN IN MIDDLE-AGED MEN Brjb: source|
|Diabetes Research and Clinical Practice||The relationship between visfatin and HOMA-IR in hypertensive patients, and the effect of antihypertensive drugs on visfatin and HOMA-IR in hypertensive patients with insulin resistance ScienceDirect: S0168822711002956|
|J Physiol Pharmacol.||Early-effect of bariatric surgery (Scopinaro method) on intestinal hormones and adipokines in insulin resistant Wistar rat. Pubmed: 24304571|
|Endocr J.||CTRP3 modulates the expression and secretion of adipokines in 3T3-L1 adipocytes Pubmed:25168658|
|Exp Ther Med.||Plasma visfatin levels and mRNA expression of visfatin in peripheral blood mononuclear cells and peripheral blood monocyte-derived macrophages from normal weight females with polycystic ovary syndrome Pubmed:Pmc3991522|
|Eur J Cancer Prev.||Visfatin derived from ascites promotes ovarian cancer cell migration through Rho/ROCK signaling-mediated actin polymerization. Pubmed:25055182|
|Genome||Visfatin −948G/T and resistin −420C/Gpolymorphisms in Egyptian type 2 diabetic patients with and without cardiovascular diseases Nrcresearchpress:Source|
|PLOS ONE||Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug PubMed: 26262991|
|Alcoholism and Drug Addiction||Changes in concentration of visfatin during four weeks of inpatient treatment of alcohol dependent males Science: Article|
|Cytokine||Variation in blood levels of hormones in obese patients following weight reduction induced by endoscopic and surgical bariatric therapies PubMed: 26539806|
|Genome||Genetic Variations in Visfatin and Resistin Genes in Egyptian Type 2 Diabetic Patients With and Without Complications PubMed: 25120107|
|Acta Histochemica||Favorable outcomes of hydroxychloroquine in insulin resistance may be accomplished by adjustment of the endothelial dysfunction as well as the skewed balance of adipokines science:S0065128116301234|
|Catalog No.||Related products for research use of Rattus norvegicus (Rat) Organism species||Applications (RESEARCH USE ONLY!)|
|RPA638Ra01||Recombinant Visfatin (VF)||Positive Control; Immunogen; SDS-PAGE; WB.|
|PAA638Ra01||Polyclonal Antibody to Visfatin (VF)||WB; IHC; ICC; IP.|
|LAA638Ra71||Biotin-Linked Polyclonal Antibody to Visfatin (VF)||WB; IHC; ICC.|
|LAA638Ra81||FITC-Linked Polyclonal Antibody to Visfatin (VF)||WB; IHC; ICC; IF.|
|MAA638Ra21||Monoclonal Antibody to Visfatin (VF)||WB; IHC; ICC; IP.|
|SEA638Ra||ELISA Kit for Visfatin (VF)||Enzyme-linked immunosorbent assay for Antigen Detection.|
|CEA638Ra||ELISA Kit for Visfatin (VF)||Enzyme-linked immunosorbent assay for Antigen Detection.|
|CGA638Ra01||cDNA of Visfatin (VF)||PCR; Protein Expression; etc.|